Comparative Tolerability of Erythromycin and Newer Macrolide Antibacterials in Paediatric Patients

ISSN： 0114-5916

Source： Drug Safety, Vol.20, Iss.1, 1999-01, pp. : 25-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Tolerability of the Newer Fluoroquinolone Antibacterials

By Ball P.

Drug Safety, Vol. 21, Iss. 5, 1999-11 ,pp. : 407-421

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of Newer Agents for Insomnia

By Zammit Gary

Drug Safety, Vol. 32, Iss. 9, 2009-09 ,pp. : 735-748

Adis International

Access to resources Recommend Favorite

Comparative Pharmacokinetics and Pharmacodynamics of the Newer Fluoroquinolone Antibacterials

By Aminimanizani A.

Clinical Pharmacokinetics, Vol. 40, Iss. 3, 2001-01 ,pp. : 169-187

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of Intravenous Erythromycin and Clarithromycin in Hospitalised Patients with Community-Acquired Pneumonia: Results of a Double-Blind, Randomised, Prospective Study

By de Celis G.

Clinical Drug Investigation, Vol. 22, Iss. 6, 2002-06 ,pp. : 393-398

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the Newer Generation Antiparkinsonian Agents

By Lambert D.

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 55-65

Adis International

Access to resources Recommend Favorite